582 Companies
Aileron Therapeutics, an American company specializing in chemoprotection oncology, is making strides in cancer treatment with its cutting-edge drug, ALRN-6924. The drug is currently undergoing sev...
Aileron Therapeutics, Inc. Annual Report 2023Late-stage clinical biopharmaceutical company, SELLAS Life Sciences Group, Inc., is leading the charge in cancer immunotherapy development across various cancer indications in the United States. Th...
SELLAS Life Sciences Group, Inc. Annual Report 2023Therapix Biosciences Ltd. is a clinical-stage pharmaceutical company specializing in cannabinoid pharmaceuticals development. Led by a seasoned team of executives and scientists, the company is foc...
Therapix Biosciences Ltd. Annual Report 2018BioXcel Therapeutics, Inc., a biopharmaceutical company that harnesses the power of artificial intelligence to develop revolutionary medicines in neuroscience and immuno-oncology, has made signific...
BioXcel Therapeutics Annual Report 2023German-based biopharmaceutical company, MorphoSys AG, is making significant strides in the development, discovery, and commercialization of therapeutic antibodies that help cancer and autoimmune di...
MorphoSys Annual Report 2023Vericel Corporation, a biopharmaceutical company focused on advanced therapies, is making waves in the sports medicine and severe burn care markets in the US. With a primary focus on the developmen...
Vericel Annual Report 2023Anavex Life Sciences Corp., a clinical stage biopharmaceutical company focused on developing drug candidates for central nervous system (CNS) diseases, announced impressive progress on its lead dru...
Anavex Life Sciences Annual Report 2022San Diego-based Mirati Therapeutics Inc. is a commercial-stage oncology company that has developed novel therapies to address the genetic and immunological promoters of cancer. Their pipeline is ro...
Mirati Therapeutics Annual Report 2021Israeli-based Kamada Ltd. specializes in plasma-derived protein therapeutics and operates in two segments, Proprietary Products and Distribution. The company's offerings include a range of treatmen...
Kamada Ltd. Annual Report 2023Opthea Limited, a prominent clinical stage biopharmaceutical company from Australia, has recently gained attention for its revolutionary therapies primarily designed to combat eye diseases. The com...
Optiva Annual Report 2023Ceapro Inc. is a Canadian biotechnology company that specializes in developing and commercializing active ingredients extracted from plants for the healthcare and cosmetic industries. Their area of...
Ceapro Inc. Annual Report 2021BlackRock, Inc. has launched a close-ended fixed income mutual fund, BlackRock Multi-Sector Income Trust, that primarily invests in loan and debt instruments and other investments with similar econ...
Biotron Limited Annual Report 2023London-based Tiziana Life Sciences Ltd is a pioneering biotech firm that specializes in the development and discovery of molecules to tackle diseases afflicting human oncology and immunology. Its f...
Tiziana Life Sciences plc Annual Report 2023Sutro Biopharma, a clinical-stage oncology company, is making headlines with its innovative work in antibody drug conjugates (ADCs) through its proprietary protein synthesis platforms, XpressCF and...
StrongPoint Annual Report 2023Cambridge-based clinical-stage biopharmaceutical company Synlogic, Inc. has announced its pioneering work in developing synthetic biotics to treat metabolic and immunological diseases in the United...
Synlogic Annual Report 2023